Physician profile
Asfandyar Khan
NPI 1750765392
$1,421.54
in general payments reported to CMS, 2019-2025
7 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $57.40 · 2022: $793 · 2023: $60.49 · 2024: $19.47 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $358 · Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $357.93 |
| Food and Beverage | $110.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $708.90 | 2022 | |
| Intuitive Surgical, INC. | $450.99 | 2022-2025 | |
| Kerecis Limited | $102.29 | 2019 | |
| Advanced Oxygen Therapy INC. | $82.49 | 2022-2023 | Topical Oxygen Chamber For Extremities |
| Biotissue Holdings INC. | $39.67 | 2021 | |
| Avanos Medical | $19.47 | 2024 | On-Q* Pump and Accessories |
| Medtronic, INC. | $17.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asfandyar Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.